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Abstract
The progression or reversal of dental caries is determined by the balance between pathological and
protective factors. It is well established that a) fluoride inhibits demineralization and enhances
remineralization, b) chlorhexidine reduces the cariogenic bacterial challenge, and c) xylitol is non-
cariogenic and has antibacterial properties. The challenge that we face is how best to deliver these
anti-caries entities at true therapeutic levels, over time, to favorably tip the caries balance. High
caries risk people, including children with Early Childhood Caries (ECC), are a special challenge,
since high cariogenic bacterial activity can override fluoride therapy. Current fluoride and
chlorhexidine varnishes deliver all their activity within about 24 hours. Early studies with
experimental slow release fluoride devices retained elevated levels of fluoride for months in a
therapeutic range but have not been pursued. Preventive dentistry has largely ignored the benefits
of reducing the bacterial challenge, partially due to primitive and inadequate delivery systems. For
example, Chlorhexidine applied as a rinse partially reduces some bacteria but not others that are
hiding within the biofilm. Better antibacterials and better delivery systems are needed. Xylitol
delivered by gum or lozenge appears to be effective clinically in reducing cariogenic bacteria and
caries levels, but novel systems that deliver therapeutic amounts when needed would be a major
advance, especially for young children. Reducing the cariogenic bacterial challenge and enhancing
the effect of fluoride by the use of new sustained-delivery systems would have a major effect on
dealing with caries as a disease.
Introduction
The Caries Balance
Progression, inhibition, or reversal of dental caries can be
determined by considering the "caries balance." This con-
cept was proposed by Featherstone [1] and has subse-
quently been simplified as the balance between three
pathological factors and three protective factors, as illus-
trated in Figure 1.
Although numerous other factors can be added to either
side, these six have been found to be the primary determi-
nants of whether the caries process is in balance, progress-
ing, or reversing [3,4]. This article specifically addresses
two protective factors, namely fluoride and extrinsic anti-
bacterials. Although chlorhexidine and xylitol are specifi-
cally discussed, the principles apply equally well to any
other antibacterial that has an effect on the cariogenic bac-
teria. For caries prevention or reversal, it is necessary to
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effectively increase the effect of one or more protective fac-
tors or to decrease the effect of one or more pathological
factors.
The primary purpose of this article is to discuss the chal-
lenges of delivering fluoride, chlorhexidine, and xylitol
more effectively. The questions to be answered are:
1) What are the effective therapeutic levels of each of these
components?
2) How best can each be delivered to the tooth surface
over time?
3) Can new technology deliver known therapeutic agents
more effectively and with fewer compliance issues than
current methods?
Fluoride
It is well known that fluoride is a major anticaries agent.
The primary mode of action for adults as well as children
is through its topical action in the mouth as it reaches the
surface of the tooth, the plaque, and the subsurface
lesions [5]. Fluoride inhibits demineralization, enhances
remineralization, and can inhibit the cariogenic bacteria.
For this discussion I will address primarily the role of flu-
oride in remineralization. Fluoride enhances reminerali-
zation of partially dissolved enamel or dentin crystals by
combining with calcium and phosphate that comes pri-
marily from saliva. Remineralization is the natural repair
process for the non-cavitated carious lesion. Fluoride
speeds up remineralization and forms a new fluorapatite-
like veneer on the remineralized crystal remnants inside
the carious lesion. The crystal solubility is markedly
reduced [6].
The level of fluoride needed to enhance remineralization
is considerably lower than that needed for the inhibition
of demineralization or for an antibacterial effect. Over
many years our laboratory has used a pH cycling model to
predict likely clinical outcomes. The model was originally
developed to mimic the early lesions formed around
orthodontic brackets in human mouths [7]. Several varia-
tions of the model have been developed, and pH cycling
has been shown to be a good indicator of fluoride effects
in the mouth [8]. The model consists of alternating peri-
ods of demineralization and remineralization in the labo-
ratory over a three-week period. Fifteen years ago we
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studied the effect of low concentrations of fluoride in the
mineralizing solution [8,9]. We studied levels ranging
from no added fluoride to 0.5 ppm F to elucidate likely
effects of fluoride at these levels in saliva. We found a lin-
ear relationship between the logarithm of the fluoride
level and the net amount of remineralization. There was a
rapid rise in effect as the fluoride concentration increased
from 0.03 ppm to 0.1 ppm F. Usual levels in saliva are
0.03 ppm F or less, dependent on the use of fluoride prod-
ucts and fluoride in the drinking water [10]. We predicted
that fluoride in saliva at 0.1 ppm would give almost com-
plete protection against caries progression. Of course a
simple number such as this does not apply to all situa-
tions and is very dependent on the strength of the acid
challenge coming form the bacterial fermentation of car-
bohydrates (see figure 1) and the intensity of the swinging
of the caries balance. However, to aim at a continual level
of 0.1 ppm F in saliva as a baseline value instead of values
of 0.03 ppm or less appears to be sound.
In a recently reported six-year clinical study in children
who started caries free at age 6 or 7 years, we found a
strong protective effect for salivary fluoride values greater
than 0.08 ppm F [11]. Most recently a study by Toumba
and Curzon [12] reported a 70% reduction in caries versus
control for high risk children who wore a fluoride-releas-
ing glass device in their mouths. The mean salivary F levels
were 0.11 ppm in the test group versus 0.03 ppm F in the
control group over a two-year period. Baseline fluoride
levels in saliva from dentifrice or mouthrinse are generally
in the 0.02 – 0.04 ppm F level, which is adequate for low
or medium caries challenge individuals, but not for high
caries challenge. Even for currently marketed fluoride var-
nish, these levels are returned to within 24 hours after a
varnish application [13].
In earlier studies funded by NIH, various polymer-based
slow-release fluoride devices were tested in a variety of
retention mechanisms (Billings and co-workers, unpub-
lished data). Again it was illustrated in these in vivo stud-
ies that fluoride could be released constantly to give
salivary F levels of around 0.1 ppm. These studies have
never led to satisfactory commercially viable devices,
although the principle was proven.
Fluoride conclusions
The conclusion from these laboratory and clinical studies
is that there is a major anticaries effect for high caries indi-
viduals if a "therapeutic level" of fluoride as a background
at around 0.1 ppm F in saliva can be achieved day and
night. Any additional fluoride delivery, such as twice daily
brushing with a fluoride toothpaste, will be a bonus. A
sustained-release device that functions to provide the
same protection as the glass device referred to above
should be the target, only in a more acceptable form to the
patients. Such a device would overcome compliance prob-
lems and could be targeted with success to high caries risk
individuals. It may not eliminate all caries, but would lead
to dramatic reductions, and in concert with antibacterial
treatments could indeed eliminate caries in these individ-
uals.
Chlorhexidine
Caries is a transmissible infection. Although the principle
of using antibacterial therapy to reduce the caries chal-
lenge has been around for a long time, it is not considered
in general dental practice. Fluoride is the primary anti-
caries entity that is considered, and drilling and filling is
the primary method to "fix" caries. Unfortunately, placing
a restoration only removes the bacteria from that particu-
lar cavity and does nothing to lower the bacterial levels in
the remainder of the mouth [14]. If the caries balance con-
cept is applied (Figure 1), then for high caries risk individ-
uals antibacterial therapy as well as fluoride therapy is
needed to swing the balance to a no-caries status. Fluoride
therapy alone is insufficient to deal with high caries chal-
lenge. If it were sufficient, then there would be very little
caries to consider, and presentations such as the present
one would be unnecessary. Therefore, we must consider
currently available antibacterial therapy against dental
caries organisms.
Chlorhexidine has been shown in numerous studies to
reduce the levels of mutans streptococci (MS) in the plaque
biofilm in human mouths [15,16]. It is much less effective
at reducing the levels of lactobacilli (LB) in human
mouths. The effect of Chlorhexidine on other acid-pro-
ducing bacteria has been little studied. We need an anti-
bacterial that also attacks effectively the lactobacilli
species that are strongly related to caries progression.
Although Chlorhexidine is effective at killing MS and LB
in the laboratory, it is much less effective in the mouth
when these organisms are in a biofilm. This is especially
the case for LB. It is not known whether this is a substan-
tivity issue, or a diffusion related phenomenon, or
whether MS and LB deeper in the biofilm cannot be effec-
tively reached for some other reason. What is known is
that chlorhexidine reduces MS but does not usually elim-
inate it except with intensive, high-concentration,
repeated applications [17]. Other common antibacterials
such as cetyl pyridinium chloride and phenol are not
effective against the cariogenic organisms in the biofilm in
the mouth.
Although numerous studies have investigated the reduc-
tion of MS and/or LB in the mouth as a result of Chlorhex-
idine therapy, most have not continued to a clinical caries
end point (see review by Anderson, 2003) [15]. A recently
completed caries clinical trial investigated whether chang-
ing caries risk status reduced the caries outcome [14].BMC Oral Health 2006, 6:S8
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High caries risk adults (1–8 frank cavities at baseline)
were treated with Chlorhexidine rinse and fluoride rinse
(0.05% NaF) over a three-year period. The control group
was given "conventional care" with no Chlorhexidine.
Bacterial and fluoride levels in saliva were assayed at six-
month intervals in both groups. Chlorhexidine (0.12% as
gluconate) was self-applied as a mouth rinse by the sub-
jects in the study once a day either for two weeks every
three months or one week every month. The Chlorhexi-
dine therapy significantly reduced the MS levels during
the 12 months that the restorative work was done, but did
not significantly reduce the LB levels. The combined Chlo-
rhexidine and fluoride rinse therapy significantly reduced
the mean overall caries risk and significantly reduced the
mean new caries in the test group. For some subjects the
therapy was very successful, whereas in others it was not.
Compliance with the use of rinses, especially one that
tastes as bad as Chlorhexidine, is a major problem to be
solved. The above-mentioned study conclusively proved
that reducing the bacterial levels, and thereby tipping the
caries balance favorably, led to reduced caries risk, and
most importantly, a reduction in new caries.
Although Chlorhexidine varnish has been marketed, a
recent clinical trial did not show any caries reducing ben-
eficial effect [18], having only an initial effect on reducing
the levels of MS. In light of the above results for multiple
applications of Chlorhexidine rinse, it is obvious that the
bacteria levels can be reduced, but not eliminated. There-
fore, ongoing antibacterial treatments are needed to bring
down the levels each time the bacteria attempt to re-estab-
lish their pathological levels.
Chlorhexidine conclusions
Intervention with multiple applications over periods of
months of 0.12% Chlorhexidine gluconate can signifi-
cantly reduce MS levels, and in combination with fluoride
therapy can markedly lower the risk for future caries.
However, the Chlorhexidine is much less effective against
LB in the mouth. Current Chlorhexidine products require
patient compliance with a rinse that tastes bad, has the
potential to stain, and has to be applied numerous times
to be effective. Work is needed to develop a delivery sys-
tem that avoids the need for patient compliance, provides
ongoing multiple doses as needed over months, and has a
carrier that provides access and killing power to the LB in
the biofilm. An improved antibacterial that is effective
against both MS and LB and has a daily-dosage mecha-
nism would be optimal.
Xylitol
Xylitol is a five carbon sugar alcohol that looks and tastes
like sucrose, and is therefore a good "sugar substitute."
Further benefits are that it is not metabolized by the cari-
ogenic bacteria and that it has antibacterial properties (see
review Lynch and Milgrom, 2003, available at http://
www.cdafoundation.org/journal)[19]. Unlike Chlorhexi-
dine mouthrinse, which cannot be used by young chil-
dren and infants because they cannot effectively rinse and
spit, and they do not tolerate the taste, Xylitol tastes like
sucrose, is sweet, and is non-cariogenic. It is ideal for
infants and young children, provided a suitable delivery
vehicle can be developed. Xylitol has great potential
because not only does it provide a substitute for the fer-
mentable carbohydrates on the pathological side of the
caries balance (Figure 1), but it also appears to function as
an antibacterial on the protective side of the balance.
Several studies have shown the clinical benefits of xylitol
in markedly inhibiting the transfer of bacteria from
mother to child. In a six-year clinical trial Soderling and
coworkers [20,21] showed that mothers who chewed xyl-
itol gum during the first two years of the children's lives
had highly significant reductions in colonization of MS,
and, very importantly, had dramatically less dental decay
five years later. This study and others[19] clearly show the
benefits of xylitol chewing gum in caries reduction by
inhibiting bacterial transfer and colonization. A recent
study in 5-year-olds further showed that chewing xylitol
gum over a six-month period actually reduced levels of MS
in the mouth [22]. Plaque scores were also reduced.
Chewing gum and mints are now available in the USA
from a variety of suppliers, and xylitol wipes that could be
used in a baby's mouth have recently become available.
The obvious question is this: What delivery vehicles can
be used for young children and infants to provide useful
dosage levels?
Xylitol Conclusions
Xylitol is a sucrose substitute that appears to be not only
non-cariogenic but also has antibacterial properties. It
inhibits transfer of cariogenic bacteria from person to per-
son and reduces bacterial recolonization over time.
Several questions remain regarding xylitol. These are:
1) What is the optimum dose per day to have an anticaries
effect?
2) Are there any undesirable side effects at the optimum
dosage level?
3) What delivery vehicles other than chewing gum are
suitable, and for what ages?
4) Are xylitol mints, which have a delivery period of a few
seconds, as effective as xylitol gum, which has a prolonged
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5) Are there any long-term negative effects of xylitol if it is
delivered daily to infants, children, or adults?
6) How can xylitol products be successfully marketed in
the US when therapeutic claims are not made?
Conclusion
There is now considerable information available on dos-
age levels for fluoride if delivered in a slow-release, long-
term delivery form. What remains is to develop an accept-
able delivery system that elevates the baseline salivary flu-
oride levels into a truly therapeutic window.
Chlorhexidine could be much more effectively delivered
as a successful antibacterial against MS, but a better anti-
bacterial is needed, especially one that is effective against
LB in the biofilm. Antibacterial therapy in conjunction
with fluoride therapy can be very effective at reducing or
eliminating caries in high risk individuals. However, the
antibacterial therapy must be delivered in a form that
overcomes lack of compliance, since high caries risk indi-
viduals are likely to be poor compliers.
Xylitol shows great promise not only as a sugar substitute,
but also as an antibacterial that can be used in infants and
for the inhibition of transfer from person to person. New
delivery vehicles are needed to effectively deliver xylitol at
therapeutically effective levels over time.
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